CN115260233B - Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe - Google Patents
Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe Download PDFInfo
- Publication number
- CN115260233B CN115260233B CN202210721904.8A CN202210721904A CN115260233B CN 115260233 B CN115260233 B CN 115260233B CN 202210721904 A CN202210721904 A CN 202210721904A CN 115260233 B CN115260233 B CN 115260233B
- Authority
- CN
- China
- Prior art keywords
- imidazole
- fluorescent molecule
- molecule containing
- type fluorescent
- fluorescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title claims abstract description 74
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical group C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 3
- 238000001917 fluorescence detection Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 17
- YFPJFKYCVYXDJK-UHFFFAOYSA-N Diphenylphosphine oxide Chemical compound C=1C=CC=CC=1[P+](=O)C1=CC=CC=C1 YFPJFKYCVYXDJK-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 12
- 239000005695 Ammonium acetate Substances 0.000 claims description 12
- 229940043376 ammonium acetate Drugs 0.000 claims description 12
- 235000019257 ammonium acetate Nutrition 0.000 claims description 12
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 claims description 11
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 10
- 230000002194 synthesizing effect Effects 0.000 claims description 9
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 claims description 8
- YYVYAPXYZVYDHN-UHFFFAOYSA-N 9,10-phenanthroquinone Chemical compound C1=CC=C2C(=O)C(=O)C3=CC=CC=C3C2=C1 YYVYAPXYZVYDHN-UHFFFAOYSA-N 0.000 claims description 7
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 claims description 6
- 229960000583 acetic acid Drugs 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- BCJVBDBJSMFBRW-UHFFFAOYSA-N 4-diphenylphosphanylbutyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCCP(C=1C=CC=CC=1)C1=CC=CC=C1 BCJVBDBJSMFBRW-UHFFFAOYSA-N 0.000 claims description 5
- 238000006289 Radziszewski imidazole synthesis reaction Methods 0.000 claims description 5
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 5
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical group C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 5
- PCLBUOLKAKSZBP-UHFFFAOYSA-N 4-diphenylphosphorylbenzaldehyde Chemical compound C1=CC(C=O)=CC=C1P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 PCLBUOLKAKSZBP-UHFFFAOYSA-N 0.000 claims description 3
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical group C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 claims 1
- -1 Al 3+ Inorganic materials 0.000 abstract description 21
- 238000001514 detection method Methods 0.000 abstract description 16
- 125000002883 imidazolyl group Chemical group 0.000 abstract description 12
- 229910021645 metal ion Inorganic materials 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 5
- 238000010791 quenching Methods 0.000 abstract description 4
- 230000000171 quenching effect Effects 0.000 abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 239000007787 solid Substances 0.000 description 18
- 238000010521 absorption reaction Methods 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 238000005481 NMR spectroscopy Methods 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 150000002460 imidazoles Chemical class 0.000 description 9
- 238000001228 spectrum Methods 0.000 description 9
- 239000001257 hydrogen Substances 0.000 description 8
- 229910052739 hydrogen Inorganic materials 0.000 description 8
- 238000006862 quantum yield reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 150000001875 compounds Chemical group 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229910052742 iron Inorganic materials 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000002189 fluorescence spectrum Methods 0.000 description 6
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- SCHRRICRQNJJKN-UHFFFAOYSA-N P.[O] Chemical group P.[O] SCHRRICRQNJJKN-UHFFFAOYSA-N 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 238000002484 cyclic voltammetry Methods 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000007614 solvation Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000004770 highest occupied molecular orbital Methods 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 4
- 238000000103 photoluminescence spectrum Methods 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000004982 aromatic amines Chemical class 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- KIQKWYUGPPFMBV-UHFFFAOYSA-N diisocyanatomethane Chemical compound O=C=NCN=C=O KIQKWYUGPPFMBV-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002256 galaktoses Chemical class 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000004776 molecular orbital Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AZUHIVLOSAPWDM-UHFFFAOYSA-N 2-(1h-imidazol-2-yl)-1h-imidazole Chemical class C1=CNC(C=2NC=CN=2)=N1 AZUHIVLOSAPWDM-UHFFFAOYSA-N 0.000 description 1
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 1
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 229910021617 Indium monochloride Inorganic materials 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 101100233916 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KAR5 gene Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- DDMXPIDWXIHIDX-UHFFFAOYSA-N [C].N1C=NC=C1 Chemical compound [C].N1C=NC=C1 DDMXPIDWXIHIDX-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- PORCMJJTZXANLJ-UHFFFAOYSA-N cyclopenta-1,3-diene iron(2+) Chemical compound [Fe++].[Fe++].c1cc[cH-]c1.c1cc[cH-]c1.c1cc[cH-]c1.c1cc[cH-]c1 PORCMJJTZXANLJ-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229910021397 glassy carbon Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 230000005525 hole transport Effects 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- APHGZSBLRQFRCA-UHFFFAOYSA-M indium(1+);chloride Chemical compound [In]Cl APHGZSBLRQFRCA-UHFFFAOYSA-M 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- CRXFROMHHBMNAB-UHFFFAOYSA-N methyl 2-isocyanoacetate Chemical compound COC(=O)C[N+]#[C-] CRXFROMHHBMNAB-UHFFFAOYSA-N 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 238000006452 multicomponent reaction Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- ZVJHJDDKYZXRJI-UHFFFAOYSA-N pyrroline Natural products C1CC=NC1 ZVJHJDDKYZXRJI-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- ORFSSYGWXNGVFB-UHFFFAOYSA-N sodium 4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonic acid Chemical compound COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C3)C(=CC(=C4N)S(=O)(=O)O)S(=O)(=O)O)O)OC)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)O)S(=O)(=O)O)O.[Na+] ORFSSYGWXNGVFB-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 238000010490 three component reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及一种荧光分子,具体涉及一种含三苯氧膦结构的咪唑型荧光分子,还涉及其制备方法以及作为检测Fe3+的荧光探针应用,属于传感技术领域。The invention relates to a fluorescent molecule, in particular to an imidazole fluorescent molecule containing a triphenylphosphine oxide structure, and also to a preparation method thereof and application as a fluorescent probe for detecting Fe 3+ , belonging to the field of sensor technology.
背景技术Background Art
咪唑衍生物是指化合物结构中含有一个或多个咪唑环结构单元的一类物质的总称。咪唑是一个含有两个氮原子的五元环,属于1,3-唑类化合物,其化学性质稳定,广泛存在于天然产物与生物活性物质中。咪唑衍生物因其抗菌、消炎等药理特性在药物合成、蛋白酶活性抑、固化剂等方面均有报道,由于咪唑环反应位点多,所以被修饰改造出来的衍生物在光电材料、传感器和荧光探针等领域的研究也层出不穷。Imidazole derivatives are a general term for a class of substances that contain one or more imidazole ring structural units in the compound structure. Imidazole is a five-membered ring containing two nitrogen atoms and belongs to the 1,3-azole class of compounds. It has stable chemical properties and is widely found in natural products and bioactive substances. Imidazole derivatives have been reported in drug synthesis, protease activity inhibition, curing agents, etc. due to their antibacterial and anti-inflammatory pharmacological properties. Due to the many reaction sites on the imidazole ring, the modified derivatives have also been studied in the fields of optoelectronic materials, sensors, and fluorescent probes.
近年来,研究者报道了大量以咪唑为基本单元所设计的材料,在室温磷光、深蓝色发光材料、力致变色、荧光传感和离子检测方面应用广泛。In recent years, researchers have reported a large number of materials designed with imidazole as the basic unit, which are widely used in room temperature phosphorescence, deep blue luminescent materials, mechanochromism, fluorescence sensing and ion detection.
如Liu等成功开发出不同激发态的芘[4,5-d]咪唑衍生物,分别为PyPA、PyPPA、PyPPAC和PyPAC。其中,PyPPA和PyPPAC具有赋予它们的混合局部和电荷转移状态、纯蓝色荧光以及高量子产率。基于PyPPA的非掺杂OLED CIE坐标为(0.14,0.13),并达到最大EQE8.47%。基于PyPPAC的非掺杂OLED最大亮度为50046cd m–2,位于蓝色区域,CIE坐标为(0.15,0.21),EQE=6.74%,亮度超过10000cd m–2。For example, Liu et al. successfully developed pyrene[4,5-d]imidazole derivatives with different excited states, namely PyPA, PyPPA, PyPPAC and PyPAC. Among them, PyPPA and PyPPAC have mixed local and charge transfer states, pure blue fluorescence and high quantum yield. The CIE coordinates of the non-doped OLED based on PyPPA are (0.14, 0.13) and the maximum EQE is 8.47%. The maximum brightness of the non-doped OLED based on PyPPAC is 50046cd m -2 , which is located in the blue region. The CIE coordinates are (0.15, 0.21), EQE = 6.74%, and the brightness exceeds 10000cd m -2 .
如Wang等设计合成了一种新的吩嗪-咪唑基席夫碱(PIS)荧光探针,已被开发用于在生理pH条件下对水性介质中的Cd2+离子进行比率检测。For example, Wang et al. designed and synthesized a new phenazine-imidazolyl Schiff base (PIS) fluorescent probe, which has been developed for ratiometric detection of Cd 2+ ions in aqueous media under physiological pH conditions.
Wang等共合成了三种新型双靶向荧光探针,并分别通过咪唑和一种半乳糖(IM-Gal-1)、两种半乳糖(IM-Gal-2)和三种半乳糖(IM-Gal-3)相连。这些探针对Fe3+显示出良好的选择性和灵敏度,化学计量比为1:2识别模式。Wang et al. synthesized three novel dual-targeted fluorescent probes, which were linked to one galactose (IM-Gal-1), two galactoses (IM-Gal-2), and three galactoses (IM-Gal-3) via imidazole. These probes showed good selectivity and sensitivity to Fe 3+ , with a stoichiometric ratio of 1:2 recognition mode.
目前,分子中同时含有咪唑和咔唑结构的有机发光分子也相继被设计合成出来。如文献(Tagare J,Dubey D K,Yadav R A K,et al.Triphenylamine-imidazole-basedluminophores for deep-blue organic light-emitting diodes:experimental andtheoretical investigations[J].Materials Advances,2020,1(4):666-679.);(Devesing Girase J,Rani Nayak S,Tagare J,et al.Solution-processed deep-blue(y~0.06)fluorophores based on triphenylamine-imidazole(donor-acceptor)forOLEDs:computational and experimental exploration[J].Journal of InformationDisplay,2021:1-15.);(Bourouina A,Rekis M.Comparison in optoelectronicproperties of triphenylamine-imidazole or imidazole as donor for dye-sensitized solar cell:theoretical approach[J].Journal of Molecular Modeling,2021,27(8):1-9.)等报道了咪唑与三苯胺相连的深蓝色有机电致发光材料,但是,目前还未见同时含有咪唑和三苯氧膦结构的有机发光分子用于荧光探针检测铁离子的相关报道。At present, organic light-emitting molecules containing both imidazole and carbazole structures in their molecules have also been designed and synthesized one after another. Such as the literature (Tagare J, Dubey D K, Yadav R A K, et al. Triphenylamine-imidazole-based luminophores for deep-blue organic light-emitting diodes: experimental and theoretical investigations [J]. Materials Advances, 2020, 1 (4): 666-679.); (Devesing Girase J, Rani Nayak S, Tagare J, et al. Solution-processed deep -blue(y~0.06)fluorophores based on triphenylamine-imidazole(donor-acceptor)forOLEDs: computational and experimental exploration[J].Journal of InformationDisplay,2021:1-15.);(Bourouina A,Rekis M.Comparison in optoelectronicproperties of triphenylamine-imidazole or imidazole as donor for dyesensit-ized solar cell:theoretical approach[J] .Journal of Molecular Modeling, 2021, 27(8):1-9.) et al. reported a deep blue organic electroluminescent material connected with imidazole and triphenylamine. However, there are currently no reports on the use of organic luminescent molecules containing both imidazole and triphenylphosphine oxide structures as fluorescent probes for the detection of iron ions.
现有技术中合成咪唑衍生物的方法也很多,如Debus-Radziszewski咪唑合成法是最经典的合成咪唑化合物的方法之一。二酮化合物和醛类化合物在胺或铵盐存在下,可以用来合成2,4,5-三芳基咪唑、菲并咪唑、双咪唑衍生物等。There are many methods for synthesizing imidazole derivatives in the prior art, such as the Debus-Radziszewski imidazole synthesis method, which is one of the most classic methods for synthesizing imidazole compounds. Diketone compounds and aldehyde compounds can be used to synthesize 2,4,5-triarylimidazoles, phenanthroimidazoles, bisimidazole derivatives, etc. in the presence of amines or ammonium salts.
Sundar和Rengan报道了以苯甲醇,1,2-二酮和过量乙酸铵为原料,进行三组分反应,在通入氧气的情况下,以0.25mol%的负载双钌(II)催化该氧化过程,唯一的副产物是水。Sundar and Rengan reported a three-component reaction of benzyl alcohol, 1,2-diketone and excess ammonium acetate as raw materials. The oxidation process was catalyzed by 0.25 mol% supported bis-Ru(II) in the presence of oxygen, and the only by-product was water.
Wang等用各种双取代的炔烃、醛和胺为原料,通过新戊酸介导发生多组分反应,简便、高效地合成了四取代咪唑衍生物。Wang et al. used various disubstituted alkynes, aldehydes and amines as raw materials and synthesized tetrasubstituted imidazole derivatives simply and efficiently through a multicomponent reaction mediated by pivalic acid.
Naidoo和Jeena采用廉价的碘/二甲基亚砜(DMSO)体系,通过“一锅、两步”法合成了2,4,5-三取代咪唑。该反应不需要借助酸性条件和金属,产率中等到良好。第一步是炔烃在I2/DMSO条件下反应得到中间体:为二取代的苯偶酰,第二步醛和乙酸铵原位反应生成三取代的咪唑化合物。Naidoo and Jeena used a cheap iodine/dimethyl sulfoxide (DMSO) system to synthesize 2,4,5-trisubstituted imidazoles through a "one-pot, two-step" method. The reaction does not require acidic conditions and metals, and the yield is moderate to good. The first step is that the alkyne reacts under I 2 /DMSO conditions to obtain an intermediate: a disubstituted benzil, and the second step is the in-situ reaction of aldehydes and ammonium acetate to generate trisubstituted imidazole compounds.
Grigg等通过异氰乙酸酯在银盐催化下均二聚化合成了咪唑化合物。在催化量的AcOAg条件下,异氰基乙酸甲酯与丙烯酸甲酯的反应形成吡咯啉,而在化学计量的AcOAg条件下,反应会发生异氰化物的均二聚化生成1,4-二取代咪唑。Grigg et al. synthesized imidazole compounds by homodimerization of isocyanate under the catalysis of silver salt. Under the condition of catalytic amount of AcOAg, methyl isocyanoacetate reacts with methyl acrylate to form pyrroline, while under the condition of stoichiometric AcOAg, the reaction will cause homodimerization of isocyanide to form 1,4-disubstituted imidazole.
Shao等报道了基于酰胺基乙腈和苯硼酸的环化反应,形成了双取代的咪唑化合物。Shao et al. reported a cyclization reaction based on amidoacetonitrile and phenylboronic acid to form disubstituted imidazole compounds.
Xie等发明了一种新型的碱介导的活性亚甲基异氰酸酯与烯酮亚胺[3+2]环化反应。该反应具有区域选择性,烯酮亚胺在t-BuOK这种强碱的条件下与活性亚甲基异氰酸酯反应得到了1,4,5-三取代咪唑衍生物。Xie et al. invented a novel base-mediated [3+2] cyclization reaction of active methylene isocyanate with ketene imine. The reaction is regioselective, and ketene imine reacts with active methylene isocyanate under the condition of a strong base such as t-BuOK to obtain 1,4,5-trisubstituted imidazole derivatives.
现有技术中合成咪唑的方法很多,并各自存在优点和缺点,目前为止还未见通过经典Suzuki偶联和Debus-Radziszewski反应构建含三苯氧膦结构的咪唑环的小分子荧光探针的相关报道。There are many methods for synthesizing imidazoles in the prior art, each of which has advantages and disadvantages. So far, there has been no report on the construction of a small molecule fluorescent probe containing an imidazole ring of a triphenylphosphine oxide structure through the classic Suzuki coupling and Debus-Radziszewski reaction.
发明内容Summary of the invention
针对现有技术存在的缺陷,本发明的第一个目的是在于提供一种含有三苯氧膦结构的咪唑型荧光分子,该分子物理和化学稳定性好,且在可见光和紫外光下表现出良好的荧光性能。In view of the defects of the prior art, the first object of the present invention is to provide an imidazole-type fluorescent molecule containing a triphenylphosphine oxide structure, which has good physical and chemical stability and exhibits good fluorescence properties under visible light and ultraviolet light.
本发明的第二个目的是在于提供一种有三苯氧膦结构的咪唑型荧光分子的制备方法,该方法原料易得,且合成步骤较为简单,产率可观,有利于扩大生产。The second object of the present invention is to provide a method for preparing an imidazole-type fluorescent molecule having a triphenylphosphine oxide structure, wherein the raw materials are readily available, the synthesis steps are relatively simple, the yield is considerable, and it is conducive to expanding production.
本发明的第三个目的是在于提供一种有三苯氧膦结构的咪唑型荧光分子的应用,将其作为检测Fe3+的荧光探针使用,荧光分子能够高选择性与Fe3+结合并产生荧光淬灭,且受Al3+、Ca2+、Li+、Cu2+、Na+、In3+等金属离子干扰小,可以用于Fe3+的荧光检测,具有灵敏度高,检出限低等特点。The third object of the present invention is to provide an application of an imidazole-type fluorescent molecule with a triphenylphosphine structure, which is used as a fluorescent probe for detecting Fe 3+ . The fluorescent molecule can bind to Fe 3+ with high selectivity and produce fluorescence quenching, and is less interfered by metal ions such as Al 3+ , Ca 2+ , Li + , Cu 2+ , Na + , In 3+, etc., and can be used for fluorescence detection of Fe 3+ , with the characteristics of high sensitivity and low detection limit.
为了实现上述技术目的,本发明提供了一种含三苯氧膦结构的咪唑型荧光分子,其具有式1或式2结构:In order to achieve the above technical objectives, the present invention provides an imidazole fluorescent molecule containing a triphenylphosphine oxide structure, which has a structure of Formula 1 or Formula 2:
其中,R为氢或芳基。Wherein, R is hydrogen or aryl.
作为一个优选的方案,所述芳基可以为苯基或者为苯基衍生的基团,如取代苯基,在苯环上还包含常见取代基团,具体如C1~C5的烷基、C1~C5的烷氧基、卤素取代基等等。本发明优选为最简单的苯环,可以延长咪唑环的共轭体系。As a preferred solution, the aryl group can be a phenyl group or a group derived from a phenyl group, such as a substituted phenyl group, and the phenyl ring also contains common substituent groups, such as C 1 to C 5 alkyl groups, C 1 to C 5 alkoxy groups, halogen substituents, etc. The present invention preferably uses the simplest benzene ring, which can extend the conjugated system of the imidazole ring.
本发明的荧光分子由咪唑结构与氧膦基通过苯环偶联形成典型的D-π-A结构,具有大共轭体系,刚性较强,其HOMO与LUMO的能隙最大差距能(ET)在3.71~3.85eV。从分子构型上看,氧膦基为电子给体(Donor)、苯环为π桥、咪唑为电子受体(Acceptor),氧膦基与多个苯基相连,增大了氧膦基的共轭性并改变了分子的空穴传输性能。此外,氧膦基的引入还能够提高荧光分子的溶解性能和热稳定性,如热稳定性均达到了250℃左右,有利于加工并拓宽其应用范围。The fluorescent molecule of the present invention is a typical D-π-A structure formed by coupling an imidazole structure and an oxygen phosphine group through a benzene ring, has a large conjugated system, is relatively rigid, and has a maximum energy gap (ET) between HOMO and LUMO of 3.71 to 3.85 eV. From the perspective of molecular configuration, the oxygen phosphine group is an electron donor, the benzene ring is a π bridge, and the imidazole is an electron acceptor. The oxygen phosphine group is connected to multiple phenyl groups, which increases the conjugation of the oxygen phosphine group and changes the hole transport performance of the molecule. In addition, the introduction of the oxygen phosphine group can also improve the solubility and thermal stability of the fluorescent molecule, such as the thermal stability reaches about 250° C., which is conducive to processing and widens its application range.
本发明还提供了一种含三苯氧膦结构的咪唑型荧光分子的合成方法,该方法包括以下步骤:The present invention also provides a method for synthesizing an imidazole-type fluorescent molecule containing a triphenylphosphine oxide structure, the method comprising the following steps:
1)二苯基氧膦和对甲酰基苯硼酸通过Suzuki偶联反应,得到4-二苯基膦酰基苯甲醛;1) Diphenylphosphine oxide and p-formylphenylboronic acid are reacted by Suzuki coupling reaction to obtain 4-diphenylphosphonylbenzaldehyde;
2)4-二苯基膦酰基苯甲醛与苯偶酰或9,10-菲醌通过Debus-Radziszewski咪唑合成反应,即得式1或式2结构化合物。2) 4-diphenylphosphonylbenzaldehyde reacts with benzil or 9,10-phenanthrenequinone via Debus-Radziszewski imidazole synthesis to obtain a compound of formula 1 or formula 2.
本发明通过两步经典的反应来合成含三苯氧膦结构的咪唑型荧光分子,先以二苯基氧膦与对甲酰基苯硼酸进行Suzuki偶联反应,合成4-二苯基膦酰基苯甲醛,再利用4-二苯基膦酰基苯甲醛与二酮化合物和芳胺(或氨)进行经典的Debus-Radziszewski咪唑合成反应,得到兼具三苯氧膦结构和咪唑结构的荧光分子。The invention synthesizes an imidazole-type fluorescent molecule containing a triphenoxyl structure through two-step classical reactions. First, diphenylphosphine oxide and p-formylphenylboronic acid are subjected to a Suzuki coupling reaction to synthesize 4-diphenylphosphinoylbenzaldehyde. Then, 4-diphenylphosphinoylbenzaldehyde is subjected to a classical Debus-Radziszewski imidazole synthesis reaction with a diketone compound and an aromatic amine (or ammonia) to obtain a fluorescent molecule having both a triphenoxyl structure and an imidazole structure.
作为一个优选的方案,二苯基氧膦和对甲酰基苯硼酸在1,4-二(二苯基膦基)丁烷、醋酸钯和碳酸钾作用下,于85~95℃温度下,反应20~24h。As a preferred solution, diphenylphosphine oxide and p-formylphenylboronic acid are reacted in the presence of 1,4-bis(diphenylphosphino)butane, palladium acetate and potassium carbonate at a temperature of 85 to 95° C. for 20 to 24 hours.
作为一个较优选的方案,二苯基氧膦和对甲酰基苯硼酸的摩尔比为1:1.5~1.6。As a more preferred solution, the molar ratio of diphenylphosphine oxide to p-formylphenylboronic acid is 1:1.5-1.6.
作为一个较优选的方案,1,4-二(二苯基膦基)丁烷的摩尔量为二苯基氧膦摩尔量的4~6%。As a more preferred solution, the molar amount of 1,4-bis(diphenylphosphino)butane is 4-6% of the molar amount of diphenylphosphine oxide.
作为一个较优选的方案,醋酸钯的摩尔量为二苯基氧膦摩尔量的4~6%。As a more preferred solution, the molar amount of palladium acetate is 4-6% of the molar amount of diphenylphosphine oxide.
作为一个较优选的方案,碳酸钾的摩尔量为二苯基氧膦摩尔量的0.4~0.6倍。As a more preferred solution, the molar amount of potassium carbonate is 0.4 to 0.6 times the molar amount of diphenylphosphine oxide.
作为一个优选的方案,4-二苯基膦酰基苯甲醛与苯偶酰或9,10-菲醌在乙酸铵和冰醋酸作用下,于115~125℃温度下,反应15~20h;或者,4-二苯基膦酰基苯甲醛与苯偶酰或9,10-菲醌及芳胺在乙酸铵和冰醋酸作用下,于115~125℃温度下,反应15~20h。As a preferred solution, 4-diphenylphosphonylbenzaldehyde reacts with benzil or 9,10-phenanthrenequinone in the presence of ammonium acetate and glacial acetic acid at a temperature of 115 to 125°C for 15 to 20 hours; or, 4-diphenylphosphonylbenzaldehyde reacts with benzil or 9,10-phenanthrenequinone and aromatic amine in the presence of ammonium acetate and glacial acetic acid at a temperature of 115 to 125°C for 15 to 20 hours.
作为一个较优选的方案,4-二苯基膦酰基苯甲醛与苯偶酰或9,10-菲醌等摩尔比。As a more preferred solution, the molar ratio of 4-diphenylphosphonylbenzaldehyde to benzil or 9,10-phenanthrenequinone is equal.
作为一个较优选的方案,乙酸铵与4-二苯基膦酰基苯甲醛的摩尔量比为2~3:1。As a more preferred solution, the molar ratio of ammonium acetate to 4-diphenylphosphonylbenzaldehyde is 2 to 3:1.
作为一个较优选的方案,乙酸铵、芳基胺与4-二苯基膦酰基苯甲醛的摩尔量比为1~1.5:1~1.5:1。As a more preferred solution, the molar ratio of ammonium acetate, arylamine and 4-diphenylphosphonylbenzaldehyde is 1 to 1.5:1 to 1.5:1.
本发明的含三苯氧膦结构的咪唑型荧光分子的合成路线具体如下(四种目标荧光分子目标产物分别为C1、C2、C3和C4):The synthetic route of the imidazole fluorescent molecule containing a triphenylphosphine oxide structure of the present invention is as follows (the four target fluorescent molecule target products are C 1 , C 2 , C 3 and C 4 ):
本发明还提供了一种含三苯氧膦结构的咪唑型荧光分子的应用,其作为检测Fe3+的荧光探针使用。本发明的含三苯氧膦结构的咪唑型荧光分子不但具有较好的荧光性能,而且还能够与Fe3+进行高选择性配位结合,Fe3+能够使其荧光发生淬灭。利用该特点,可以实现Fe3+的荧光检测,且具有检测灵敏度高,下限低等特点。The present invention also provides an application of an imidazole type fluorescent molecule containing a triphenylphosphine structure, which is used as a fluorescent probe for detecting Fe 3+ . The imidazole type fluorescent molecule containing a triphenylphosphine structure of the present invention not only has good fluorescence performance, but also can be highly selectively coordinated with Fe 3+ , and Fe 3+ can quench its fluorescence. Utilizing this feature, fluorescence detection of Fe 3+ can be achieved, and has the characteristics of high detection sensitivity, low lower limit, etc.
作为一个优选的方案,含三苯氧膦结构的咪唑型荧光分子的应用于Al3+、Ca2+、Li+、Cu2+、Na+、In3+中至少一种与Fe3+共存体系中Fe3+的荧光检测。本发明的含咔唑结构的咪唑型荧光分子对Fe3+的作用选择性高,各类金属离子对铁离子的干扰小。As a preferred solution, the imidazole fluorescent molecule containing a triphenylphosphine oxide structure is applied to the fluorescence detection of Fe 3+ in a system where at least one of Al 3+ , Ca 2+ , Li + , Cu 2+ , Na + , and In 3+ coexists with Fe 3+ . The imidazole fluorescent molecule containing a carbazole structure of the present invention has high selectivity for Fe 3+ , and various metal ions have little interference with iron ions.
相对现有技术,本发明技术方案带来的有益技术效果:Compared with the prior art, the technical solution of the present invention has the following beneficial technical effects:
本发明的荧光分子均具有较好的热稳定性,如荧光分子C1、C2、C3和C4,均达到了250℃左右。The fluorescent molecules of the present invention all have good thermal stability, for example, the thermal stability of the fluorescent molecules C 1 , C 2 , C 3 and C 4 all reaches about 250°C.
本发明的荧光分子具有较好的荧光性能,荧光分子C1和C2在可见光下呈纯白色,365nm紫外灯下显蓝色荧光,其中,C3和C4在可见光下呈浅黄色,365nm紫外灯下表现为蓝绿色荧光,C2的荧光量子产率最高(56.35%),C4的荧光寿命最长(5.1147ns)。The fluorescent molecules of the present invention have good fluorescence properties. The fluorescent molecules C1 and C2 are pure white under visible light and show blue fluorescence under 365nm ultraviolet light. Among them, C3 and C4 are light yellow under visible light and show blue-green fluorescence under 365nm ultraviolet light. C2 has the highest fluorescence quantum yield (56.35%) and C4 has the longest fluorescence lifetime (5.1147ns).
本发明的荧光分子同时具有三苯氧膦结构和咪唑结构,荧光分子C1~C4均能与金属Fe3+发生络合反应,使得分子的荧光受到抑制对铁离子表现出较高的选择性,其在溶剂中的荧光强度随着铁离子的加入而受到明显削弱,甚至淬灭,从而可以作为三价铁离子检测的荧光探针,其中C3表现出最佳的选择性,可用于定量检测Fe3+。计算结果表明,4种分子的荧光强度与铁离子浓度均存在一定的线性关系,测得检出限LOD分别为9.61×10–5M、7.98×10–5M、6.75×10–5M和8.02×10–5M。The fluorescent molecules of the present invention have both triphenylphosphine structure and imidazole structure. The fluorescent molecules C1 to C4 can all react with metal Fe 3+ to form a complex, so that the fluorescence of the molecules is suppressed and they show high selectivity for iron ions. The fluorescence intensity in the solvent is significantly weakened or even quenched with the addition of iron ions, so that they can be used as fluorescent probes for trivalent iron ion detection. Among them, C3 shows the best selectivity and can be used for quantitative detection of Fe 3+ . The calculation results show that there is a certain linear relationship between the fluorescence intensity of the four molecules and the iron ion concentration, and the detection limits LOD are 9.61× 10-5 M, 7.98× 10-5 M, 6.75× 10-5 M and 8.02× 10-5 M, respectively.
本发明的荧光分子合成方法和步骤简单,可以通过经典的Suzuki偶联和Debus-Radziszewski咪唑合成反应等合成,且原料易得,产率可观,有利于扩大生产。The fluorescent molecule synthesis method and steps of the present invention are simple, and can be synthesized through classic Suzuki coupling and Debus-Radziszewski imidazole synthesis reaction, etc., and the raw materials are easily available, the yield is considerable, and it is conducive to expanding production.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为荧光分子C1的1H NMR图谱。FIG1 is the 1 H NMR spectrum of the fluorescent molecule C1.
图2为荧光分子C1的13C NMR图谱。FIG2 is the 13 C NMR spectrum of the fluorescent molecule C1.
图3为荧光分子C1的H RMS图谱。FIG3 is the HRMS spectrum of the fluorescent molecule C1.
图4为荧光分子C1~C4的FTIR光谱。FIG4 shows the FTIR spectra of fluorescent molecules C1 to C4.
图5为荧光分子C1~C4经归一化处理后的紫外可见吸收光谱。FIG5 is the normalized UV-visible absorption spectra of fluorescent molecules C1 to C4.
图6(a)为荧光分子C1~C4的固态荧光发射光谱;(b)为荧光分子C1~C4经归一化处理后的固态荧光发射光谱。FIG6 (a) is the solid-state fluorescence emission spectra of fluorescent molecules C1 to C4; FIG6 (b) is the solid-state fluorescence emission spectra of fluorescent molecules C1 to C4 after normalization.
图7(a)为荧光分子C1~C4的色度坐标;(b)为荧光分子C1~C4在自然光(i)和365nm紫外光(ii)下的照片。FIG7 (a) is the chromaticity coordinates of fluorescent molecules C1-C4; (b) is a photograph of fluorescent molecules C1-C4 under natural light (i) and 365 nm ultraviolet light (ii).
图8(A)为C1在五种不同极性溶剂(1×10–5mol/L)中的PL光谱;(B)C2在五种不同极性溶剂中的PL光谱(1×10–5mol/L)。Figure 8 (A) shows the PL spectra of C1 in five solvents with different polarities (1×10 –5 mol/L); (B) shows the PL spectra of C2 in five solvents with different polarities (1×10 –5 mol/L).
图9(C)为C3在五种不同极性溶剂中的PL光谱(1×10–5mol/L);(D)C4在五种不同极性溶剂中的PL光谱(1×10–5mol/L)。Figure 9 (C) shows the PL spectra of C3 in five solvents with different polarities (1×10 –5 mol/L); (D) shows the PL spectra of C4 in five solvents with different polarities (1×10 –5 mol/L).
图10为荧光分子C1~C4在不同离子溶液中的荧光发射光谱(1a,2a,3a,4a)和直方图(1b,2b,3b,4b)。FIG10 shows the fluorescence emission spectra (1a, 2a, 3a, 4a) and histograms (1b, 2b, 3b, 4b) of fluorescent molecules C1 to C4 in different ionic solutions.
图11为荧光分子C1~C4在365nm紫外线照射下的荧光图像;THF/H2O(fW=20%)溶液中的样品浓度为1×10–5mol/L。FIG. 11 is a fluorescence image of fluorescent molecules C1 to C4 under 365 nm ultraviolet irradiation; the sample concentration in THF/H 2 O (f W = 20%) solution is 1×10 –5 mol/L.
图12(a)为C1在不同Fe3+浓度溶液中的荧光光谱;(b)为C1的荧光发射强度随Fe3+浓度的变化而变化;THF/H2O(fW=20%)溶液中的样品浓度为1×10–5mol/L;Fe3+的浓度为0~1×10–2mol/L。Figure 12 (a) shows the fluorescence spectra of C1 in solutions with different Fe 3+ concentrations; (b) shows the fluorescence emission intensity of C1 changing with the Fe 3+ concentration; the sample concentration in THF/H 2 O (f W =20%) solution is 1×10 –5 mol/L; the Fe 3+ concentration is 0~1×10 –2 mol/L.
图13为荧光分子C1~C4的CV曲线。FIG. 13 shows the CV curves of fluorescent molecules C1 to C4.
具体实施方式DETAILED DESCRIPTION
以下实施例旨在进一步详细说明本发明内容,而不是限制权利要求的保护范围。The following examples are intended to further illustrate the present invention in detail, rather than to limit the scope of protection of the claims.
以下实施例中涉及的检测方法和仪器:The detection methods and instruments involved in the following examples are:
用Bruker-Avance 400MHz核磁共振仪,测试1H(400MHz)和13C(100MHz)核磁共振谱,以CDCl3或DMSO-d6为溶剂,以四甲基硅烷(TMS)为内标,化学位移以ppm表示,所有耦合常数(J值)以赫兹(Hz)表示。Bruker-Avance 400 MHz NMR instrument was used to measure 1 H (400 MHz) and 13 C (100 MHz) NMR spectra, with CDCl 3 or DMSO-d 6 as solvent and tetramethylsilane (TMS) as internal standard. Chemical shifts were expressed in ppm and all coupling constants (J values) were expressed in Hertz (Hz).
用Perkin-Elmer SP One红外分光光度计,进行红外光谱分析,采用溴化钾(KBr)压片。Infrared spectroscopy was performed using a Perkin-Elmer SP One infrared spectrophotometer using potassium bromide (KBr) pellets.
用WC-1型显微熔点仪测定所制备化合物的熔点,温度未经校正。The melting points of the prepared compounds were determined using a WC-1 micro melting point apparatus, and the temperatures were not corrected.
用日立U-3100分光光度计测试紫外-可见吸收光谱(波长:200–800nm)。The UV-visible absorption spectra (wavelength: 200–800 nm) were measured using a Hitachi U-3100 spectrophotometer.
用Hamamatsu稳态瞬态荧光光谱仪(Edinburgh Instruments,FLS980),在325nm条件下的HeCd激光激发下测试荧光光谱。The fluorescence spectrum was measured using a Hamamatsu steady-state transient fluorescence spectrometer (Edinburgh Instruments, FLS980) under HeCd laser excitation at 325 nm.
在AV1301A电化学工作站(上海辰华仪器有限公司)上进行循环伏安法(CV)测量,扫描速率为50mV/s,三个电极由铂丝工作电极、铂丝对电极和银/氯化银参比电极组成。Cyclic voltammetry (CV) measurements were performed on an AV1301A electrochemical workstation (Shanghai Chenhua Instrument Co., Ltd.) with a scan rate of 50 mV/s. The three electrodes consisted of a platinum wire working electrode, a platinum wire counter electrode, and a silver/silver chloride reference electrode.
以下实施例中涉及的化学药剂,如果没有特殊说明,均为常规的市售药品。The chemical agents involved in the following examples, unless otherwise specified, are conventional commercially available drugs.
实施例1Example 1
(1)4-二苯基膦酰基苯甲醛的合成(1) Synthesis of 4-diphenylphosphonylbenzaldehyde
在氮气气氛下,将二苯基磷氧(5mmol)、4-甲酰基苯硼酸(7.5mmol)、1,4-二(二苯基膦基)丁烷(0.25mmol)、醋酸钯(0.25mmol)、碳酸钾(2.5mmol)和15mL二氧六环,依次加入到50mL带聚四氟乙烯支管口的烧瓶中,在90℃下反应24h。反应结束后,趁热用硅藻土过滤,再加饱和食盐水和二氯甲烷萃取,干燥得到粗产物,经柱层析分离纯化(洗脱剂为石油醚/二氯甲烷,体积比为10:1),得到白色固体,产率约为71%。1H NMR(400MHz,CDCl3):δ(ppm)=9.88(d,J=15.4Hz,1H),7.78(s,2H),7.36–7.14(m,12H).Under nitrogen atmosphere, diphenylphosphine oxide (5mmol), 4-formylphenylboronic acid (7.5mmol), 1,4-bis(diphenylphosphino)butane (0.25mmol), palladium acetate (0.25mmol), potassium carbonate (2.5mmol) and 15mL dioxane were added to a 50mL flask with a polytetrafluoroethylene branch pipe mouth in sequence, and reacted at 90℃ for 24h. After the reaction, it was filtered with diatomaceous earth while hot, extracted with saturated salt water and dichloromethane, and dried to obtain a crude product, which was separated and purified by column chromatography (eluent: petroleum ether/dichloromethane, volume ratio: 10:1) to obtain a white solid with a yield of about 71%. 1 H NMR (400MHz, CDCl 3 ): δ(ppm)=9.88(d,J=15.4Hz,1H),7.78(s,2H),7.36–7.14(m,12H).
(2)2-(4-二苯基膦酰基苯基)-4,5-二苯基-1H-咪唑(C1)的合成(2) Synthesis of 2-(4-diphenylphosphonylphenyl)-4,5-diphenyl-1H-imidazole (C1)
在氮气环境中,于150mL三颈烧瓶中加入苯偶酰(5mmol)、乙酸铵(10mmol)、4-二苯基膦酰基苯甲醛(5mmol)和冰醋酸(20mL),在120℃下反应18h。结束后静置冷却至室温,加入适量水,析出灰色固体。抽滤、水洗、干燥,得到粗产物。经柱层析分离纯化(洗脱剂为石油醚/乙酸乙酯,体积比为10:1),得到白色固体,产率为74%;熔点为239–240℃。1H NMR(400MHz,DMSO-d6):δ(ppm)=12.94(s,1H),8.27–8.20(m,2H),7.79–7.62(m,8H),7.62–7.49(m,8H),7.46(t,J=7.3Hz,2H),7.40(d,J=7.1Hz,1H),7.31(t,J=7.4Hz,2H),7.23(t,J=7.2Hz,1H);13C NMR(100MHz,CDCl3):δ(ppm)=145.43,137.90,137.11,137.00,135.55,134.13,133.91,133.72,131.49,131.32,129.54,129.33,129.26,129.15,129.09,128.98,128.66,128.33,127.55,127.04,125.88,125.81;HRMS Calculated for C33H26N2OP[M+H]+m/z 497.1777,found 497.1770.In a nitrogen environment, benzil (5mmol), ammonium acetate (10mmol), 4-diphenylphosphonylbenzaldehyde (5mmol) and glacial acetic acid (20mL) were added to a 150mL three-necked flask and reacted at 120℃ for 18h. After the reaction, the mixture was allowed to stand and cool to room temperature, and an appropriate amount of water was added to precipitate a gray solid. The crude product was obtained by suction filtration, washing with water and drying. The crude product was separated and purified by column chromatography (eluent was petroleum ether/ethyl acetate, volume ratio was 10:1) to obtain a white solid with a yield of 74%; the melting point was 239–240℃. 1 H NMR (400MHz, DMSO-d 6 ): δ (ppm) = 12.94 (s, 1H), 8.27–8.20 (m, 2H), 7.79–7.62 (m, 8H), 7.62–7.49 (m, 8H), 7.46 (t, J = 7.3Hz, 2H), 7.40 (d, J = 7.1Hz, 1H), 7.31(t,J=7.4Hz,2H),7.23(t,J=7.2Hz,1H); 13 C NMR (100MHz, CDCl 3 ): δ (ppm) = 145.43, 137.90, 137.11, 137.00, 135.55, 134.13, 133.91, 133.72, 131.49, 131.32, 129.54, 129.33, 129.26, 129.15, 129.09, 128.98, 12 8.66,128.33,127.55,127.04,125.88,125.81; HRMS Calculated for C 33 H 26 N 2 OP[M+H] + m/z 497.1777, found 497.1770.
(3)2-(4-二苯基膦酰基苯基)-1,4,5-三苯基-1H-咪唑(C2)的合成(3) Synthesis of 2-(4-diphenylphosphonylphenyl)-1,4,5-triphenyl-1H-imidazole (C2)
在氮气环境中,于150mL三颈烧瓶中加入苯偶酰(5mmol)、乙酸铵(5mmol)、苯胺(5mmol)、4-二苯基膦酰基苯甲醛(5mmol)和冰醋酸(20mL),在120℃下反应20h。结束后静置冷却至室温,加入适量水,析出灰色固体。抽滤、水洗、干燥,得到粗产物。经柱层析分离纯化(洗脱剂为石油醚/乙酸乙酯,体积比为10:1),得到白色固体,产率约为78%;熔点为223–225℃。1H NMR(400MHz,CDCl3):δ(ppm)=7.60(ddd,J=31.2,17.8,8.1Hz,1H),7.45(t,J=6.3Hz,1H),7.33–7.27(m,1H),7.25–7.15(m,1H),7.12(d,J=6.9Hz,1H),7.04(d,J=7.1Hz,1H);13C NMR(100MHz,CDCl3):δ(ppm)=145.56,138.71,136.68,134.02,133.83,132.78,132.71,132.15,132.05,132.02,131.92,131.72,131.08,130.22,129.37,128.71,128.60,128.48,128.44,128.30,128.23,127.37,126.88;HRMS Calculated for C39H30N2OP[M+H]+m/z 573.2090,found 573.2100.In a nitrogen environment, benzil (5mmol), ammonium acetate (5mmol), aniline (5mmol), 4-diphenylphosphonylbenzaldehyde (5mmol) and glacial acetic acid (20mL) were added to a 150mL three-necked flask and reacted at 120℃ for 20h. After the reaction, the mixture was allowed to stand and cool to room temperature, and an appropriate amount of water was added to precipitate a gray solid. The crude product was obtained by suction filtration, washing with water and drying. The crude product was separated and purified by column chromatography (eluent was petroleum ether/ethyl acetate, volume ratio was 10:1) to obtain a white solid with a yield of about 78%; the melting point was 223–225℃. 1 H NMR (400MHz, CDCl 3 ): δ (ppm) = 7.60 (ddd, J = 31.2, 17.8, 8.1Hz, 1H), 7.45 (t, J = 6.3Hz, 1H), 7.33–7.27 (m, 1H), 7.25–7.15 (m, 1H), 7.12 (d, J = 6.9Hz, 1H), 7.0 4(d, J=7.1Hz, 1H); 13 C NMR (100MHz, CDCl 3 ): δ (ppm) = 145.56, 138.71, 136.68, 134.02, 133.83, 132.78, 132.71, 132.15, 132.05, 132.02, 131.92, 131.72, 131.08, 130.22, 129.37, 128.71, 12 8.60,128.48,128.44,128.30,128.23,127.37,126.88; HRMS Calculated for C 39 H 30 N 2 OP[M+H] + m/z 573.2090, found 573.2100.
(4)2-(4-二苯基膦酰基苯基)-1H-菲并[9,10-d]咪唑(C3)的合成(4) Synthesis of 2-(4-diphenylphosphonylphenyl)-1H-phenanthro[9,10-d]imidazole (C3)
与C1合成方法类似,浅黄色固体,产率为58%;熔点为247–249℃。1H NMR(400MHz,CDCl3):δ(ppm)=8.70(t,J=8.4Hz,1H),8.58(d,J=7.6Hz,1H),8.43(d,J=6.6Hz,1H),8.28(d,J=7.4Hz,1H),7.88(dd,J=11.1,8.2Hz,1H),7.83–7.40(m,7H);13C NMR(100MHz,CDCl3):δ(ppm)=160.84,145.24,135.62,132.73,132.63,132.26,132.20,132.10,131.59,130.63,129.55,128.96,128.77,128.65,127.53,127.36,126.99,126.87,126.77,126.37,126.00,123.76,123.44,122.92,120.95,120.82.HRMS Calculated for C33H24N2OP[M+H]+m/z 495.1621,found 495.1602.Similar to the synthesis method of C1, light yellow solid, yield 58%; melting point 247-249°C. 1 H NMR (400 MHz, CDCl 3 ): δ (ppm) = 8.70 (t, J = 8.4 Hz, 1H), 8.58 (d, J = 7.6 Hz, 1H), 8.43 (d, J = 6.6 Hz, 1H), 8.28 (d, J = 7.4 Hz, 1H), 7.88 (dd, J = 11.1, 8.2 Hz, 1H), 7.83-7.40 (m, 7H); 13 C NMR (100 MHz, CDCl 3 ): δ (ppm) = 160.84, 145.24, 135.62, 132.73, 132.63, 132.26, 132.20, 132.10, 131.59, 130.63, 129.55, 128.96, 128.77, 128.65, 127.53, 127.36, 12 6.99,126.87,126.77,126.37,126.00,123.76,123.44,122.92,120.95,120.82.HRMS Calculated for C 33 H 24 N 2 OP[M+H] + m/z 495.1621,found 495.1602.
(5)1-苯基-2-(4-二苯基磷酰基苯基)-1H-菲并[9,10-d]咪唑(C4)的合成(5) Synthesis of 1-phenyl-2-(4-diphenylphosphorylphenyl)-1H-phenanthro[9,10-d]imidazole (C4)
与C2合成方法类似,淡白色固体,产率为55%;熔点为242–243℃。1H NMR(400MHz,DMSO-d6):δ(ppm)=8.90(dd,J=20.8,8.3Hz,2H),8.68(d,J=7.8Hz,1H),7.88–7.48(m,19H),7.34(t,J=7.6Hz,1H),7.07(d,J=8.2Hz,1H),5.95(s,1H);13C NMR(100MHz,CDCl3):δ(ppm)=149.45,138.35,137.60,132.64,132.27,132.14,132.11,132.08,132.05,131.95,131.59,130.39,130.16,129.50,129.24,129.12,128.93,128.64,128.56,128.52,128.41,127.39,127.07,126.40,125.86,125.24,124.14,123.17,122.89,122.70,120.95;HRMS Calculated forC39H28N2OP[M+H]+m/z 571.1934,found.571.1932.Similar to the synthesis method of C2, pale white solid, yield 55%; melting point 242-243°C. 1 H NMR (400 MHz, DMSO-d 6 ): δ (ppm) = 8.90 (dd, J = 20.8, 8.3 Hz, 2H), 8.68 (d, J = 7.8 Hz, 1H), 7.88-7.48 (m, 19H), 7.34 (t, J = 7.6 Hz, 1H), 7.07 (d, J = 8.2 Hz, 1H), 5.95 (s, 1H); 13 C NMR (100 MHz, CDCl 3 ):δ(ppm)=149.45,138.35,137.60,132.64,132.27,132.14,132.11,132.08,132.05,131.95,131.59,130.39,130.16,129.50,129.24,129.12,128.93,128.64,128.56,128.52,128.41,127.39,127.07,126.40,125.86,125.24,124.14,123.17,122.89,122.70,120.95;HRMS Calculated forC 39 H 28 N 2 OP[M+H] + m/z 571.1934,found.571.1932.
结构表征:Structural characterization:
对上述C1~C4四个咪唑分子进行了核磁共振氢谱、碳谱和傅里叶红外光谱的结构表征。4-二苯基膦酰基苯甲醛的氢谱,在化学位移值10.0ppm附近出现了醛基1号位氢的特征单峰,个数为1,且总的氢原子数与谱图中的总积分数相同,表明该醛被成功制备。C1的氢谱如图1所示,化学位移值13.0ppm附近出现了咪唑环中N–H键的氢单峰,8.25ppm附近为三苯氧膦结构中2号位苯环上氢的双峰;其余氢均在芳香区附近,氢原子总数与氢谱中剩余积分数相等。综合C1的碳谱图2、质谱图3:145.430ppm处的峰位为咪唑2号碳的特征峰,且总的碳峰数小于等于C1中相同化学环境的碳总数;质谱中分子加氢离子后理论值为497.1777,真实值为497.1770,符合质谱标准分子量误差范围,说明C1被成功合成。The structures of the four imidazole molecules C1 to C4 were characterized by nuclear magnetic resonance hydrogen spectrum, carbon spectrum and Fourier transform infrared spectrum. The hydrogen spectrum of 4-diphenylphosphonylbenzaldehyde showed a characteristic single peak of hydrogen at the 1st position of the aldehyde group near the chemical shift value of 10.0ppm, with a number of 1, and the total number of hydrogen atoms was the same as the total integral fraction in the spectrum, indicating that the aldehyde was successfully prepared. The hydrogen spectrum of C1 is shown in Figure 1. The hydrogen single peak of the N-H bond in the imidazole ring appeared near the chemical shift value of 13.0ppm, and the double peak of hydrogen on the 2nd position of the benzene ring in the triphenylphosphine oxide structure appeared near 8.25ppm; the remaining hydrogens were all near the aromatic region, and the total number of hydrogen atoms was equal to the remaining integral fraction in the hydrogen spectrum. Comprehensive carbon spectrum Figure 2 and mass spectrum Figure 3 of C1: the peak at 145.430ppm is the characteristic peak of imidazole carbon No. 2, and the total number of carbon peaks is less than or equal to the total number of carbons in the same chemical environment in C1; the theoretical value of the molecule after hydrogenation in the mass spectrum is 497.1777, and the actual value is 497.1770, which is within the standard molecular weight error range of the mass spectrometry, indicating that C1 was successfully synthesized.
C1~C4的傅里叶红外光谱图,如图4所示。3440cm–1处为C1和C3结构中咪唑N–H键的振动吸收峰,由于C1~C4中均含有苯环、氧膦双键和咪唑环碳氮双键等结构,于是它们有着相同的吸收峰,如:3051cm–1附近为苯环的=C–H伸缩振动吸收峰,1603cm–1为咪唑环中C=N特征吸收峰,1580cm–1、1600cm–1为苯环C=C吸收峰,1190cm–1附近为P=O特征吸收峰。The Fourier infrared spectra of C1 to C4 are shown in Figure 4. The vibration absorption peak of the imidazole N-H bond in the C1 and C3 structures is at 3440 cm -1 . Since C1 to C4 all contain structures such as benzene rings, phosphine oxide double bonds, and imidazole ring carbon-nitrogen double bonds, they have the same absorption peaks, such as: 3051 cm -1 is the =C-H stretching vibration absorption peak of the benzene ring, 1603 cm -1 is the characteristic absorption peak of C=N in the imidazole ring, 1580 cm -1 and 1600 cm -1 are the absorption peaks of C=C of the benzene ring, and 1190 cm -1 is the characteristic absorption peak of P=O.
紫外光谱:UV spectrum:
将C1~C4分别溶于THF溶液中,配制成浓度均为1×10–5mol/L的待测液,而后进行紫外可见吸收光谱测试,经过归一化处理后如图5所示;从图5中可以看到C1和C2有两个明显的吸收带,大致在240nm和330nm左右;化合物C3和C4有五个较为明显的吸收带,大致在250nm、260nm、335nm、345nm和365nm附近。240nm、250nm和260nm处的吸收带应为苯环基团的π–π*跃迁引起,后330nm附近吸收带属于咪唑的P–P*跃迁。C2较C1相比,330nm左右的吸收带蓝移了13nm左右,可能是咪唑N–H键被苯环取代后,分子的共轭程度更高的缘故;C4与C3相比较,330nm以上的三个波带吸收峰位置无明显变化,可能与它们的结构十分相似有关。C1 to C4 were dissolved in THF solution to prepare the test solution with a concentration of 1×10 –5 mol/L, and then UV-visible absorption spectrum test was performed. After normalization, it is shown in Figure 5. From Figure 5, it can be seen that C1 and C2 have two obvious absorption bands, approximately around 240nm and 330nm; compounds C3 and C4 have five relatively obvious absorption bands, approximately around 250nm, 260nm, 335nm, 345nm and 365nm. The absorption bands at 240nm, 250nm and 260nm should be caused by the π-π* transition of the benzene ring group, and the absorption band near 330nm belongs to the P-P* transition of imidazole. Compared with C1, the absorption band of C2 around 330nm has blue-shifted by about 13nm, which may be due to the higher degree of conjugation of the molecule after the N-H bond of imidazole is replaced by a benzene ring; compared with C3, there is no obvious change in the positions of the three absorption peaks of C4 above 330nm, which may be related to their very similar structures.
固态荧光分析:Solid-state fluorescence analysis:
通过稳态瞬态荧光光谱仪测试了C1~C4在固态下的荧光性质。图6(a)和图6(b)分别为固态下C1~C4荧光发射光谱图和其归一化图。图7(a)和图7(b)分别为其色坐标图和在自然光下或365nm紫外灯下固体照片,表1为固态下化合物C1~C4的激发波长、发射波长、荧光寿命和荧光量子产率等数据。由此可知,在可见光下除C4为淡黄色固体外,其余均为白色固体;在365nm紫外灯下C1~C4大致呈蓝绿色荧光,这与色坐标图中C1~C4坐标所在光区颜色一致,且发射波长均为400nm左右。其中,C1的固态荧光发射强度最大,为2.76×105(a.u.),C4的荧光寿命最长,为5.1147ns,C2的荧光量子产率最高为56.35%。由于C1和C2结构相近,C2在C1的基础上增加了一个苯环,同样地,C4比C3多引入了一个苯环,分别比较它们的荧光寿命和荧光量子产率可知,苯环的引入能提高相应化合物的荧光寿命和荧光量子产率(比如,C2的荧光量子产率为56.35%,C1的为17.62%;C4的荧光寿命为5.1147ns,C3的为0.4778ns)。这可能是苯环的引入,使得整个分子的电子在整个共轭体系中更加平均化,不仅增加了共轭程度,而且一定程度上调节了分子中的给受体能力。这为今后设计和调控性能更为优异的发光基团提供了很好的策略。The fluorescence properties of C1-C4 in the solid state were tested by a steady-state transient fluorescence spectrometer. Figure 6(a) and Figure 6(b) are the fluorescence emission spectra of C1-C4 in the solid state and their normalized graphs, respectively. Figure 7(a) and Figure 7(b) are their color coordinate diagrams and solid photos under natural light or 365nm ultraviolet light, respectively. Table 1 shows the excitation wavelength, emission wavelength, fluorescence lifetime and fluorescence quantum yield of compounds C1-C4 in the solid state. It can be seen that except for C4, which is a light yellow solid under visible light, the rest are white solids; under 365nm ultraviolet light, C1-C4 are roughly blue-green fluorescence, which is consistent with the color of the light area where the C1-C4 coordinates are located in the color coordinate diagram, and the emission wavelength is about 400nm. Among them, C1 has the largest solid-state fluorescence emission intensity, which is 2.76×10 5 (au), C4 has the longest fluorescence lifetime, which is 5.1147ns, and C2 has the highest fluorescence quantum yield, which is 56.35%. Since C1 and C2 have similar structures, C2 adds a benzene ring on the basis of C1. Similarly, C4 introduces one more benzene ring than C3. By comparing their fluorescence lifetimes and fluorescence quantum yields, it can be seen that the introduction of benzene rings can improve the fluorescence lifetimes and fluorescence quantum yields of the corresponding compounds (for example, the fluorescence quantum yield of C2 is 56.35%, that of C1 is 17.62%; the fluorescence lifetime of C4 is 5.1147ns, and that of C3 is 0.4778ns). This may be because the introduction of benzene rings makes the electrons of the entire molecule more averaged in the entire conjugated system, which not only increases the degree of conjugation, but also regulates the donor-acceptor capacity in the molecule to a certain extent. This provides a good strategy for the design and regulation of luminescent groups with better performance in the future.
表1.荧光分子C1~C4荧光数据Table 1. Fluorescence data of fluorescent molecules C1 to C4
a固体粉末的最大激发波长. aThe maximum excitation wavelength of solid powder.
b固体粉末的最大发射波长. b Maximum emission wavelength of solid powder.
c固体粉末的荧光强度. c Fluorescence intensity of solid powder.
d固体粉末的荧光寿命. d Fluorescence lifetime of solid powder.
e固体粉末的荧光量子产率. e Fluorescence quantum yield of solid powder.
溶剂化效应:Solvation Effects:
表2.C1~C4在五种溶剂中的最大发射波长a Table 2. Maximum emission wavelengths a of C1-C4 in five solvents
a溶液浓度:1×10–5mol/L。 aSolution concentration: 1×10 –5 mol/L.
选取了溶解性较好的五种溶剂:DMF、丙酮、二氯甲烷、四氢呋喃和甲苯,分别对C1~C4进行了溶剂化效应分析。5种溶剂的最大吸收波长数据见表2,其测试液浓度均为1×10–5mol/L,图8中(A)、(B)和图9中(C)、(D)分别对应着C1~C4在五种不同溶剂中的液态荧光发射的归一化光谱和液态荧光照片。分析可知:C1~C4均无明显的溶剂化变色效应,液态荧光均为蓝光,其中,C3的吸收波长随溶剂极性的增加有着逐渐增大的变化,即红移;没出现溶剂化效应的原因可能是C3在这五种溶剂中体现得不明显,但是就液态荧光来看,C3具备溶剂化效应的可能性不大。Five solvents with good solubility were selected: DMF, acetone, dichloromethane, tetrahydrofuran and toluene, and the solvation effect of C1~C4 was analyzed respectively. The maximum absorption wavelength data of the five solvents are shown in Table 2. The test solution concentration is 1× 10-5 mol/L. Figure 8 (A), (B) and Figure 9 (C), (D) correspond to the normalized spectra and liquid fluorescence photos of C1~C4 in five different solvents. Analysis shows that: C1~C4 have no obvious solvation color change effect, and the liquid fluorescence is blue light. Among them, the absorption wavelength of C3 has a gradually increasing change with the increase of solvent polarity, that is, red shift; the reason for the lack of solvation effect may be that C3 is not obvious in these five solvents, but from the perspective of liquid fluorescence, it is unlikely that C3 has a solvation effect.
金属离子检测性能分析:Metal ion detection performance analysis:
(1)金属离子选择性检测:(1) Selective detection of metal ions:
选用以氯离子作为阴离子、不同金属阳离子的无机盐,排除阴离子的干扰。含氯离子的7种无机盐:分别是AlCl3、CuCl2、LiCl、NaCl、CaCl2、InCl3和FeCl3,选用THF/H2O(fw=30%)的混合溶液为溶剂;以C1为例,先配制含有C1且样品浓度为的1×10-5mol/L的四氢呋喃/水(fw=30%)的混合溶液3mL,后分别称量一定量的无机盐,分别加入到混合溶液中,使其金属离子浓度为1×10-2mol/L,轻轻摇晃后置于超声波清洗仪中,设置超声功率为100%、时间定为30min,待金属离子与含样品的试液充分络合后,静置24h后马上进行液态荧光发射测试,确保含不同金属离子的测试液在同一电压、同一激发波长和同一批次下进行,C2~C3做法相同。Select inorganic salts with chloride ions as anions and different metal cations to eliminate the interference of anions. Seven kinds of inorganic salts containing chloride ions: AlCl 3 , CuCl 2 , LiCl, NaCl, CaCl 2 , InCl 3 and FeCl 3 , a mixed solution of THF/H 2 O (f w = 30%) was selected as the solvent; taking C1 as an example, 3 mL of a mixed solution of tetrahydrofuran/water (f w = 30%) containing C1 and having a sample concentration of 1×10 -5 mol/L was first prepared, and then a certain amount of inorganic salts were weighed and added to the mixed solution to make the metal ion concentration 1×10 -2 mol/L, and then gently shaken and placed in an ultrasonic cleaning instrument, and the ultrasonic power was set to 100% and the time was set to 30 min. After the metal ions were fully complexed with the test solution containing the sample, the liquid fluorescence emission test was immediately performed after standing for 24 hours to ensure that the test solutions containing different metal ions were tested under the same voltage, the same excitation wavelength and the same batch. The same method was used for C2 to C3.
C1~C4的荧光发射曲线如图10所示,结合它们在365nm紫外等下的液态荧光照片图11分析可知:它们的最大荧光发射强度在Al3+、Li+、Na+、Ca2+、In3+溶液中的荧光发射强度保持较高水平,甚至有的略带增强,在Cu2+溶液中均存在一定的荧光抑制,不是特别明显,但在Fe3+溶液中均存在很强的荧光抑制现象,荧光几近消失。这可能是因为含咪唑结构的C1和C3具有未被取代的N–H键,其N上的孤对电子可以和Fe3+结合形成络合物,破坏了分子的共轭体系和分子间的聚集方式,从而削弱了C1和C3在四氢呋喃水溶液中的荧光。通过初步的离子筛选发现:C1和C3可以选择性感知Fe3+。C2和C4具体原因不知,但均有作为Fe3+荧光探针的潜力。The fluorescence emission curves of C1 to C4 are shown in Figure 10. Combined with their liquid fluorescence photos under 365nm ultraviolet light, Figure 11, it can be seen that their maximum fluorescence emission intensities in Al 3+ , Li + , Na + , Ca 2+ , and In 3+ solutions remain at a high level, and some are even slightly enhanced. There is a certain fluorescence inhibition in Cu 2+ solution, which is not particularly obvious, but there is a strong fluorescence inhibition phenomenon in Fe 3+ solution, and the fluorescence almost disappears. This may be because C1 and C3 containing imidazole structures have unsubstituted N-H bonds, and the lone pair of electrons on their N can combine with Fe 3+ to form a complex, destroying the conjugated system of the molecule and the aggregation mode between molecules, thereby weakening the fluorescence of C1 and C3 in tetrahydrofuran aqueous solution. Through preliminary ion screening, it was found that C1 and C3 can selectively sense Fe 3+ . The specific reasons for C2 and C4 are unknown, but both have the potential to be Fe 3+ fluorescent probes.
(2)金属离子灵敏性检测:(2) Metal ion sensitivity detection:
通过上一步金属离子选择性分析,发现Fe3+对C1~C4的液态荧光强度具有很强的抑制作用,可以考虑将C1~C4应用于Fe3+检测中。以C1为例,在一定的浓度范围内,配制了Fe3+浓度分别为0、0.005×10-2M、0.0125×10-2M、0.02×10-2M、0.0275×10-2M、0.035×10- 2M、0.1×10-2M和1×10-2M的样品溶液,样品溶液为含C1的浓度为1×10-5M的四氢呋喃/水溶液(fw=30%),待摇振均匀后,置于超声清洗仪中超声30min,功率定为100%,超声完毕后再静置老化一天,随后立即进行不同浓度Fe3+的液态荧光发射测试。Through the metal ion selectivity analysis in the previous step, it was found that Fe 3+ has a strong inhibitory effect on the liquid fluorescence intensity of C1~C4, and C1~C4 can be considered to be applied to Fe 3+ detection. Taking C1 as an example, within a certain concentration range, sample solutions with Fe 3+ concentrations of 0, 0.005× 10-2 M, 0.0125× 10-2 M, 0.02 × 10-2 M, 0.0275× 10-2 M, 0.035× 10-2 M, 0.1× 10-2 M and 1× 10-2 M were prepared. The sample solution was a tetrahydrofuran/water solution ( fw = 30%) containing C1 at a concentration of 1× 10-5 M. After shaking evenly, it was placed in an ultrasonic cleaner for 30 minutes, with the power set to 100%. After the ultrasonication was completed, it was left to age for one day, and then the liquid fluorescence emission test of different concentrations of Fe 3+ was immediately carried out.
根据Stern–Volmer方程:I0/I=1+KSV[Fe3+],拟合它们的线性关系,其中I0和I分别是C1在最高荧光发射波长下不加Fe3+和加Fe3+后的荧光发射强度,[Fe3+]代表铁离子浓度变化值,KSV是Stern–Volmer常数。然后根据公式LOD=3σ/K计算,其中LOD代表离子检出限,σ为C1不加Fe3+时测量15次空白溶剂的荧光发射强度的标准偏差,K表示拟合的线性函数斜率,即为KSV值。According to the Stern–Volmer equation: I 0 /I=1+K SV [Fe 3+ ], their linear relationship was fitted, where I 0 and I are the fluorescence emission intensities of C1 without Fe 3+ and with Fe 3+ at the highest fluorescence emission wavelength, [Fe 3+ ] represents the change in iron ion concentration, and K SV is the Stern–Volmer constant. Then the formula LOD=3σ/K was used for calculation, where LOD represents the ion detection limit, σ is the standard deviation of the fluorescence emission intensity of blank solvent measured 15 times when C1 does not add Fe 3+ , and K represents the slope of the fitted linear function, which is the K SV value.
如图12,C1对不同浓度的Fe3+荧光猝灭响应存在规律性的变化,其荧光发射强度随离子浓度增加而呈现线性减弱。根据Stern–Volmer方程我们计算得出C1的LOD为9.61×10- 5M,其线性方程为I0/I=1.6417+7770[Fe3+](R2=0.9965),其中R2达到0.99左右,可以认为它具有了作为荧光探针的精度标准。其余C2~C4的线性方程拟合同上做法。As shown in Figure 12, the fluorescence quenching response of C1 to different concentrations of Fe 3+ has regular changes, and its fluorescence emission intensity decreases linearly with the increase of ion concentration. According to the Stern–Volmer equation, we calculated that the LOD of C1 is 9.61×10 - 5 M, and its linear equation is I 0 /I=1.6417+7770[Fe 3+ ](R 2 =0.9965), where R 2 reaches about 0.99, which can be considered to have the accuracy standard as a fluorescent probe. The linear equations of the remaining C2 to C4 are similar to the above method.
电化学性能分析:Electrochemical performance analysis:
以C1为例:以四丁基六氟磷酸铵为电解质、脱氧THF为溶剂,称取一定质量的C1,配成浓度为1mg/mL的待测液,待测液经过除氧处理后立即进行CV测试。选用Ag/AgCl作为参比电极,且氧化还原电位使用二茂铁–二茂铁校准(Fc–Fc+)氧化还原对作为外部标准;铂丝为辅助电极,玻碳电极为工作电极进行测试。先打开电脑主机、循环伏安测试软件,连接电化学工作站,待接通稳定后进行参数设定:扫描速率设定6.25mV/s,圈数定为4,电压范围经过测试不断优化。Take C1 as an example: tetrabutylammonium hexafluorophosphate is used as the electrolyte and deoxygenated THF is used as the solvent. A certain mass of C1 is weighed to prepare a test solution with a concentration of 1 mg/mL. The test solution is deoxygenated and immediately subjected to CV testing. Ag/AgCl is selected as the reference electrode, and the redox potential is calibrated using ferrocene-ferrocene (Fc–Fc + ) redox pair as the external standard; platinum wire is used as the auxiliary electrode and the glassy carbon electrode is used as the working electrode for testing. First, turn on the computer host and cyclic voltammetry test software, connect the electrochemical workstation, and set the parameters after the connection is stable: the scan rate is set to 6.25mV/s, the number of turns is set to 4, and the voltage range is continuously optimized after testing.
表3.荧光分子C1~C4的电化学性能Table 3. Electrochemical properties of fluorescent molecules C1 to C4
aTheonset of oxidation potentials relative to Fc–Fc+couple. a Theonset of oxidation potentials relative to Fc–Fc + couple.
bEstimated from absorption onset. b Estimated from absorption onset.
cDetermined from Eonset OX. c Determined from E onset OX .
dEstimated from Eonset OX and Eg. d Estimated from E onset OX and E g.
经过如此往复过程后得到C1~C4的循环伏安测试曲线图13。根据图和计算公式将其氧化及还原电位和电化学数据列入表3。用 Eg=(1240/λ起始)(eV)、ELUMO=(EHOMO+Eg)(eV)公式计算最高分子轨道(HOMO)能级和最低分子轨道(LUMO)能级,λ起始可由紫外可见吸收光谱的起始波长估计。After such a reciprocating process, the cyclic voltammetry test curve of C1 to C4 is obtained in Figure 13. According to the figure and calculation formula, the oxidation and reduction potentials and electrochemical data are listed in Table 3. The highest molecular orbital (HOMO) energy level and the lowest molecular orbital (LUMO) energy level are calculated using the formulas E g =(1240/λ start )(eV), E LUMO =(E HOMO +E g )(eV). λ start can be estimated from the onset wavelength of the UV-visible absorption spectrum.
通过上述计算公式得到:C1、C2、C3、C4的HOMO/LUMO的结果分别为-4.74/-1.03eV;-5.32/-1.47eV;-5.25/-1.56eV;-5.29/-1.58eV。同样地,计算出了C1~C4的电化学能量间隙分别是3.71eV、3.85eV、3.69eV、3.71eV。相差不大,而且分别对比C1和C3,C2和C4可知,苯环的引入可以增大相似结构分子的能量间隙。Through the above calculation formula, we can get the HOMO/LUMO results of C1, C2, C3, and C4 as -4.74/-1.03eV, -5.32/-1.47eV, -5.25/-1.56eV, and -5.29/-1.58eV, respectively. Similarly, the electrochemical energy gaps of C1 to C4 are calculated to be 3.71eV, 3.85eV, 3.69eV, and 3.71eV, respectively. The difference is not big, and by comparing C1 and C3, and C2 and C4, respectively, we can see that the introduction of benzene rings can increase the energy gap of molecules with similar structures.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210721904.8A CN115260233B (en) | 2022-06-24 | 2022-06-24 | Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210721904.8A CN115260233B (en) | 2022-06-24 | 2022-06-24 | Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115260233A CN115260233A (en) | 2022-11-01 |
CN115260233B true CN115260233B (en) | 2024-10-18 |
Family
ID=83761585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210721904.8A Active CN115260233B (en) | 2022-06-24 | 2022-06-24 | Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115260233B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117069765A (en) * | 2023-07-07 | 2023-11-17 | 黑龙江大学 | Phenylphosphine compound containing phenanthroimidazole, preparation method and application thereof |
CN117003792A (en) * | 2023-07-11 | 2023-11-07 | 西北工业大学 | A kind of phosphorized p-hydroxybenzaldehyde compound and its assisted method for preparing octreotide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103509054A (en) * | 2012-09-21 | 2014-01-15 | Tcl集团股份有限公司 | Phosphorescence host material as well as preparation method and application of phosphorescence host material and electrically-induced phosphorescence luminescent device |
CN103865526A (en) * | 2014-04-03 | 2014-06-18 | 吉林大学 | Main material based on phenanthrene and imidazole derivative and electroluminescent device |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101794217B1 (en) * | 2015-09-18 | 2017-11-07 | 인제대학교 산학협력단 | Phosphoryl derivatives with new structures and organic electronic devices using the same |
CN105255481B (en) * | 2015-11-16 | 2017-04-05 | 齐齐哈尔大学 | A kind of phenanthro- imidazoles coumarin pair fluorophor ratio fluorescent molecular probe and its synthesis and using method for iron ion detection |
CN106496269A (en) * | 2016-09-21 | 2017-03-15 | 武汉华星光电技术有限公司 | Triphenyl phosphorus oxygen derivative and electro-phosphorescent luminescent device |
CN106831864B (en) * | 2017-01-23 | 2019-04-19 | 黑龙江大学 | Preparation method and application of delayed fluorescence host and electron transport material based on phenylbenzimidazole unipolar thermal excitation |
CN112194679A (en) * | 2020-09-23 | 2021-01-08 | 广东工业大学 | Diphenyloxyphosphorus-substituted phenanthroimidazole compound and preparation method and application thereof |
-
2022
- 2022-06-24 CN CN202210721904.8A patent/CN115260233B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103509054A (en) * | 2012-09-21 | 2014-01-15 | Tcl集团股份有限公司 | Phosphorescence host material as well as preparation method and application of phosphorescence host material and electrically-induced phosphorescence luminescent device |
CN103865526A (en) * | 2014-04-03 | 2014-06-18 | 吉林大学 | Main material based on phenanthrene and imidazole derivative and electroluminescent device |
Also Published As
Publication number | Publication date |
---|---|
CN115260233A (en) | 2022-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ziessel et al. | Isocyanate-, isothiocyanate-, urea-, and thiourea-substituted boron dipyrromethene dyes as fluorescent probes | |
Lo et al. | Cyclometalated iridium (III) diimine bis (biotin) complexes as the first luminescent biotin-based cross-linkers for avidin | |
Debsharma et al. | Aggregation-induced emission active donor–acceptor fluorophore as a dual sensor for volatile acids and aromatic amines | |
CN115260233B (en) | Imidazole type fluorescent molecule containing triphenylphosphine oxide structure, preparation method thereof and application of imidazole type fluorescent molecule as fluorescent probe | |
Cvejn et al. | Tripodal molecules with triphenylamine core, diazine peripheral groups and extended π-conjugated linkers | |
Tabasi et al. | Pyrenoimidazolyl-benzaldehyde fluorophores: Synthesis, properties, and sensing function for fluoride anions | |
Ezzayani et al. | Complex of hexamethylenetetramine with magnesium-tetraphenylporphyrin: Synthesis, structure, spectroscopic characterizations and electrochemical properties | |
Schmitt et al. | Diaryldistyrylpyrazines: solvatochromic and acidochromic fluorophores | |
Hu et al. | Conformationally locked salicylideneaniline derivatives with strong ESIPT fluorescence | |
JP2019509977A (en) | Luminescent compound | |
Chen et al. | D–π–A–π–D type solvatochromic fluorescence probes based on triphenylamine: Synthesis, photophysical properties and application | |
Ganapathi et al. | Synthesis, structure, spectral, electrochemical and sensing properties of 3-amino boron-dipyrromethene and its derivatives | |
CN108503657B (en) | Boron-nitrogen doped fused ring aromatic hydrocarbon containing five-membered heterocycle and synthetic method and application thereof | |
Asthana et al. | Recent advances in AIEgen-based chemosensors for small molecule detection, with a focus on ion sensing | |
Fei et al. | Highly sensitive TNT photoluminescent sensing by a phosphorescent complex | |
Aliprandi et al. | Chiral Amplification by Self‐Assembly of Neutral Luminescent Platinum (II) Complexes | |
Banerjee | Phenazines as chemosensors of solution analytes and as sensitizers in organic photovoltaics. | |
Lenora et al. | Thermally stable fluorogenic Zn (II) sensor based on a bis (benzimidazole) pyridine-linked phenyl-silsesquioxane polymer | |
Ma et al. | Comparation of multiple terminal functional groups dendrimer silicon (IV) phthalocyanines: Photoinduced electron/energy transfer and electrochemical properties | |
Lee et al. | Pyridazine–carbazole based fluorescent probes for volatile acid detection | |
Frizon et al. | ESIPT-based benzazole-pyromellitic diimide derivatives. A thermal, electrochemical, and photochemical investigation | |
Nayak et al. | Multifunctional 4, 5-Diphenyl-1 H-Imidazole-Based Luminogens as Near UV/Deep Blue Emitters/Hosts for Organic Light-Emitting Diodes and Selective Picric Acid Detection | |
Pandhare et al. | Synthesis of D− A based violet− red light emitting indolo [2, 3-b] quinoxalin-2-yl (phenyl) methanone amine dyes: Opto-electrochemical, AIE, and theoretical properties | |
Rajakumar et al. | Synthesis and photophysical properties of chiral dendrimers with quinoline surface group via click chemistry | |
Balandier et al. | N-aryl pyrrolo-tetrathiafulvalene based ligands: synthesis and metal coordination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |